Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
2001

Thymidylate Synthase and Colorectal Cancer Response to 5FU

Sample size: 76 publication Evidence: moderate

Author Information

Author(s): Wong N A C S, Brett L, Stewart M, Leitch A, Longley D B, Dunlop M G, Johnston P G, Lessells A M, Jodrell D I

Primary Institution: Department of Pathology, University of Edinburgh Medical School

Hypothesis

The study investigates the relationship between nuclear thymidylate synthase expression and response to 5-fluorouracil in colorectal carcinoma.

Conclusion

Higher nuclear expression of thymidylate synthase is associated with poorer response to 5-fluorouracil therapy in colorectal carcinoma.

Supporting Evidence

  • Stronger nuclear thymidylate synthase expression was linked to more mucin production in colorectal cancer.
  • Higher thymidylate synthase expression was associated with a worse response to 5-fluorouracil therapy.
  • Metastatic colorectal cancer generally showed higher thymidylate synthase expression than matched primary tumors.

Takeaway

This study found that a protein called thymidylate synthase in colorectal cancer cells can affect how well patients respond to a certain cancer treatment.

Methodology

Immunohistochemical analysis of thymidylate synthase expression in 52 primary colorectal carcinoma cases and 24 matched metastatic cases.

Participant Demographics

52 cases of primary colorectal carcinoma and 24 cases of matched metastatic carcinoma.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2001.2175

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication